Matrix metalloproteinases in cardiovascular diseaseRôle des métalloprotéinases matricielles dans la maladie cardiovasculaire
References (25)
- et al.
Cardiac mast cell- and chymase-mediated matrix metalloproteinase activity and left ventricular remodeling in mitral regurgitation in the dog
J Mol Cell Cardiol
(2003) - et al.
Different expression of MMPs/TIMP-1 in human atherosclerotic lesions. Relation to plaque features and vascular bed
Atherosclerosis
(2003) Matrix metalloproteinases and their inhibitors in connective tissue remodeling
FASEB J
(1991)- et al.
Matrix metalloproteinases: Structures, evolution, and diversification
FASEB J
(1998) - et al.
A matrix metalloproteinase induction/activation system exists in the human left ventricular myocardium and is upregulated in heart failure
Circulation
(2000) - et al.
Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure
Nat Med
(1999) - et al.
Excessive tumor necrosis factor activation after infarction contributes to susceptibility of myocardial rupture and left ventricular dysfunction
Circulation
(2004) - et al.
Intracellular action of matrix metalloproteinase-2 accounts for acute myocardial ischemia and reperfusion injury
Circulation
(2002) - et al.
Evidence for altered balance between matrix metalloproteinases and their inhibitors in human aortic diseases
Circulation
(1997) - et al.
Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques
J Clin Invest
(1994)
Loss of matrix metalloproteinase-9 or matrix metalloproteinase-12 protects apolipoprotein E-deficient mice against atherosclerotic media destruction but differentially affects plaque growth
Circulation
(2004)
A serine elastase inhibitor reduces inflammation and fibrosis and preserves cardiac function after experimentally-induced murine myocarditis
Nat Med
(1998)
Cited by (148)
Protease detection in the biosensor era: A review
2024, Biosensors and BioelectronicsMolecularly targeted nanomedicine enabled by inorganic nanoparticles for atherosclerosis diagnosis and treatment
2023, Advanced Drug Delivery Reviews
Copyright © 2006 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.